Egyptian International Pharmaceutical Industries Company (EGX:PHAR)
Egypt
· Delayed Price · Currency is EGP 70.60
-1.82 (-2.51%)
At close: Dec 4, 2025
EGX:PHAR Ratios and Metrics
Market cap in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 3, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 11,914 | 6,829 | 5,430 | 3,621 | 4,155 | 4,309 | Upgrade
|
| Market Cap Growth | 66.86% | 25.78% | 49.96% | -12.86% | -3.57% | -34.63% | Upgrade
|
| Enterprise Value | 20,261 | 14,578 | 9,630 | 5,388 | 5,509 | 5,532 | Upgrade
|
| Last Close Price | 70.60 | 43.17 | 32.68 | 23.71 | 25.05 | 24.17 | Upgrade
|
| PE Ratio | 9.48 | 6.23 | 6.60 | 5.63 | 8.52 | 8.86 | Upgrade
|
| Forward PE | 9.30 | 7.03 | 5.92 | 5.77 | 6.23 | 7.52 | Upgrade
|
| PS Ratio | 1.28 | 0.90 | 1.04 | 0.92 | 1.22 | 1.49 | Upgrade
|
| PB Ratio | 1.84 | 1.47 | 1.27 | 1.12 | 1.40 | 1.51 | Upgrade
|
| P/TBV Ratio | 1.93 | 1.48 | 1.28 | 1.12 | 1.40 | 1.52 | Upgrade
|
| P/OCF Ratio | 20.96 | - | 58.71 | - | 10.83 | 26.14 | Upgrade
|
| PEG Ratio | - | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 | Upgrade
|
| EV/Sales Ratio | 2.18 | 1.92 | 1.84 | 1.36 | 1.62 | 1.92 | Upgrade
|
| EV/EBITDA Ratio | 8.03 | 9.12 | 7.33 | 7.10 | 6.35 | 7.61 | Upgrade
|
| EV/EBIT Ratio | 8.38 | 9.70 | 7.95 | 8.14 | 7.09 | 9.42 | Upgrade
|
| EV/FCF Ratio | -13.90 | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 1.42 | 1.98 | 1.15 | 0.88 | 0.59 | 0.63 | Upgrade
|
| Debt / EBITDA Ratio | 3.89 | 5.76 | 3.74 | 3.76 | 2.03 | 2.47 | Upgrade
|
| Asset Turnover | 0.58 | 0.60 | 0.63 | 0.66 | 0.66 | 0.61 | Upgrade
|
| Inventory Turnover | 1.46 | 1.46 | 1.36 | 1.21 | 1.08 | 1.03 | Upgrade
|
| Quick Ratio | 0.47 | 0.45 | 0.65 | 0.54 | 0.67 | 1.02 | Upgrade
|
| Current Ratio | 1.43 | 1.38 | 1.94 | 1.72 | 2.13 | 2.13 | Upgrade
|
| Return on Equity (ROE) | 22.48% | 24.60% | 21.95% | 20.71% | 16.78% | 16.81% | Upgrade
|
| Return on Assets (ROA) | 8.83% | 7.41% | 9.04% | 6.89% | 9.46% | 7.77% | Upgrade
|
| Return on Capital (ROIC) | 9.64% | 8.14% | 9.90% | 7.63% | 10.36% | 8.53% | Upgrade
|
| Return on Capital Employed (ROCE) | 20.10% | 15.80% | 16.90% | 16.10% | 21.70% | 17.70% | Upgrade
|
| Earnings Yield | 10.55% | 16.04% | 15.14% | 17.76% | 11.74% | 11.29% | Upgrade
|
| FCF Yield | -12.23% | -60.34% | -40.48% | -23.75% | -1.28% | -0.90% | Upgrade
|
| Dividend Yield | 2.12% | 3.48% | 3.06% | 4.22% | 5.99% | - | Upgrade
|
| Payout Ratio | 48.57% | 39.61% | 37.67% | 61.14% | 78.64% | 103.41% | Upgrade
|
| Buyback Yield / Dilution | -13.45% | - | -50.00% | - | -1.64% | 1.61% | Upgrade
|
| Total Shareholder Return | -11.32% | 3.48% | -46.94% | 4.22% | 4.35% | 1.61% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.